Abstract # 2464 Erlotinib and Chemoradiation in Patients with Surgically Resected Locally Advanced Squamous Head and Neck Cancer (HNSCC): A Gicor Phase I Study

Presenter: Arias de la Vega, Fernando

< Back to topics

> Cover Page, Authors, Institutions

> Purpose/Objective

> Materials/Methods

> Results/Discussion

> Conclusions

> View tables/images/videos

F. Arias de la Vega1, I. Herruzo2, A. de la Torre3, M. de las Heras4, V. Arrazubi1, J. Contreras2, I. Prieto5, J. A. García Sáenz4, F. A. Calvo5, 1Hospital de Navarra, Pamplona, Spain, 2Hospital Carlos Haya, Málaga, Spain, 3Hospital Puerta de Hierro, Madrid, Spain, 4Hospital Clínico San Carlos, Madrid, Spain, 5Hospital Gregorio Marañón, Madrid, Spain

Author Disclosure:
 F. Arias de la Vega, None; I. Herruzo, None; A. de la Torre, None; M. de las Heras, None; V. Arrazubi, None; J. Contreras, None; I. Prieto, None; J.A. García Sáenz, None; F.A. Calvo, None.

E-mail a friend about this abstract:
Enter email address: